Thus, as suggested by Patanè, combining miRNAs that influence the ST2/IL-33 pathway and repeatedly measuring ST2 has the potential to clarify the role of ST2 in patients with HF [44]. This evidence concerns the gene IL1RL1 and hydrops fetalis.